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ABSTRACT
Introduction: Patients who survive an intensive care
unit admission frequently suffer physical and
psychological morbidity for many months after
discharge. Current rehabilitation pathways are often
fragmented and little is known about the optimum
method of promoting recovery. Many patients suffer
reduced quality of life.
Methods and analysis: The authors plan
a multicentre randomised parallel group complex
intervention trial with concealment of group allocation
from outcome assessors. Patients who required more
than 48 h of mechanical ventilation and are deemed fit
for intensive care unit discharge will be eligible.
Patients with primary neurological diagnoses will be
excluded. Participants will be randomised into one of
the two groups: the intervention group will receive
standard ward-based care delivered by the NHS
service with additional treatment by a specifically
trained generic rehabilitation assistant during ward
stay and via telephone contact after hospital discharge
and the control group will receive standard ward-based
care delivered by the current NHS service. The
intervention group will also receive additional
information about their critical illness and access to
a critical care physician. The total duration of the
intervention will be from randomisation to
3 months postrandomisation. The total duration of
follow-up will be 12 months from randomisation for
both groups. The primary outcome will be the
Rivermead Mobility Index at 3 months. Secondary
outcomes will include measures of physical and
psychological morbidity and function, quality of life
and survival over a 12-month period. A health
economic evaluation will also be undertaken. Groups
will be compared in relation to primary and secondary
outcomes; quantitative analyses will be supplemented
by focus groups with patients, carers and healthcare
workers.
Ethics and dissemination: Consent will be
obtained from patients and relatives according to
patient capacity. Data will be analysed according
to a predefined analysis plan.
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ARTICLE SUMMARY
Article focus
- The optimum method to maximise the rate and
magnitude of recovery following an illness
requiring intensive care is unknown.
- Rehabilitation is a complex healthcare interven-
tion, which following critical illness involves
multiple healthcare professionals including
doctors, nurses, physical therapists, dietitians,
occupational therapists and other allied
professionals.
- The RECOVER trial hypothesises that providing
more coordinated and intensive rehabilitation,
delivered by a specialised generic rehabilitation
assistant supported by the existing multidisci-
plinary team, will improve recovery as judged by
a range of patient-centred outcome measures
and is cost-effective.
Key messages
- The RECOVER study will evaluate whether
enhanced rehabilitation is clinically effective and
cost-effective in patients enrolled at the time of
ICU discharge.
- Both positive and negative results will be
clinically important in guiding future research
directions and health service improvement.
Strengths and limitations of this study
- RECOVER was informed by the recommenda-
tions of recent evidence-based NICE guidance,
and a significant body of research was used to
develop the intervention.
- The trial has been designed to adhere closely to
recent guidance concerning the evaluation of
complex healthcare interventions, especially the
measurement of process.
- A weakness may be the inclusion of patients with
a range of illness severity and disability from
a general intensive care population; this could
miss important effects in patient subgroups.
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Trial registration: The trial is registered as ISRCTN09412438 and
funded by the Chief Scientist Office, Scotland.
INTRODUCTION AND BACKGROUND
Survivors of critical illness frequently suffer from severe
disabilities that include physical, psychological, and social
problems. These typically persist for many months, may
not resolve completely1e3 and are associated with reduced
health-related quality of life (HRQoL), which often fails to
achieve preillness levels.1e4 The direct (healthcare) and
indirect (carers/family) costs during this period are
probably high but are not well studied. In the UK, a recent
report (‘Quality Critical Care’)5 and a NICE guideline6
have highlighted the need to improve rehabilitation for
this patient group. A systematic review undertaken during
NICE guideline development indicated a lack of high-
quality research concerning what interventions improve
patient outcomes and their clinical and cost-effectiveness.6
Recommended future research questions included: “For
patients at high risk of critical illness-associated morbidity,
what is the clinical effectiveness and cost effectiveness of
organised critical care rehabilitation versus usual care on
physical and psychological functioning, participation and
quality of life?”
Our pretrial work identified the following key issues in
this area:
Patients have wide ranging health problems: the health
problems that follow critical illness have been called the
‘post-ICU syndrome’.2 Physical impairment is typified by
malnutrition, which is worsened by poor appetite and
nausea. Patients can lose 10%e30% of their body mass
during critical illness.3 Recovery is further delayed by
joint stiffness, pain and neuropathies; levels of fatigue
and breathlessness are high. Muscle weakness is partic-
ularly common and strongly associated with poor
outcome. Problems with psychological health and social
functioning are also common.7 8 Anxiety, depression and
post-traumatic psychopathology (such as post-traumatic
stress disorder) are reported in 10%e40% of patients.
These problems are rarely screened for or addressed in
most acute hospitals.
Patient rehabilitation is currently not coordinated: survivors
are currently managed in acute hospitals with inconsis-
tent fragmented strategies post-intensive care unit (ICU)
discharge. Typically, specialty-based teams lead care and
patients are widely dispersed within the hospital.
Importantly, patients effectively ‘compete’ with less sick
patient groups (eg, elective surgery patients) for limited
rehabilitation resource. In a local audit, we found that
70% of patients were discharged directly home from the
acute hospital without clearly planned rehabilitation.9
Coordination with primary care services was poor and
inconsistent, and knowledge of the specific problems
faced by the post-ICU patient was very limited among
staff on the general wards and after discharge to the
community.
Patients are major users of acute hospital resource: intensive
care costs are high, mainly because of the high staffing
levels required to provide multiple organ support on an
individual patient basis. The duration of ICU stay is
skewed towards a median stay of 2e3 days in most
healthcare systems, but the minority of patients
requiring longer ICU stay utilise the majority of ICU bed
days and continue to utilise enormous hospital resource
post-ICU discharge as a result of their residual disability.
As the population ages and numbers of ICU admissions
are expected to increase, this cohort of ICU survivors will
place increasing pressure on acute hospital services.
Clinically effective rehabilitation strategies therefore
have potential to be both efficient and cost-effective.
Patient outcomes are poor: many patients report poor pre-
ICU HRQoL and have chronic health problems prior to
ICU admission,1 but HRQoL is significantly reduced in
most patients following ICU discharge. Impaired phys-
ical function is particularly common during the first
3e6 months after discharge.1 4 Typically, recovery of
HRQoL takes at least 12 months. Over 50% of patients
are below retirement age and only half of those previ-
ously working have returned to work by 12 months.
Patients have an excess risk of death compared with age-
and sex-matched population for up to 5 years after
discharge.10
Little research has evaluated interventions to improve
outcomes following ICU discharge. A small randomised
controlled trial (RCT) showed that self-help manuals,
supported by a researcher, improved physical function at
6 months.11 A recent randomised trial found improve-
ments in physical function at hospital discharge associ-
ated with early mobilisation in the ICU but did not
address longer term patient benefits or report cost-
effectiveness.12 Many critical care services provide nurse-
led follow-up clinics at 3e12 months after hospital
discharge, but this approach has little, if any, emphasis
on the early recovery phase and a recent randomised
trial was unable to demonstrate any clinical benefits or
cost-effectiveness.13
Our pretrial work included a qualitative interview-
based study evaluating the experience of 20 survivors of
long-term ventilation during the 6 months following
ICU discharge.14 We found that patients experienced
profound debilitation during the ward phase of recovery
and were frustrated by fragmented or specialty-led care,
which seemed neither to take account of their individual
needs nor issues specific to critical illness. Many were
distressed by a perceived indifference among busy ward
staff towards their significant dependence and needs.
Concerns focused on the brevity and perceived inade-
quacy of rehabilitative provision (especially physio-
therapy), while others felt ‘outside’ the rehabilitation
process, in terms of their individual contribution and
longer term goals and strategies. Many patients were
discharged home with limited understanding of the
nature or severity of their critical illness, which contrib-
uted to unrealistic expectations of recovery. In general,
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patients were ill equipped to manage their own recovery
following hospital discharge and had limited access to
clinicians in order to address their concerns. We devel-
oped a service model based around a generic rehabili-
tation assistant (GRA) to coordinate and deliver
rehabilitation for these patients throughout their
hospital stay and maintain contact after hospital
discharge.15 In our model, rehabilitation is planned and
supervised by ‘hard-stretched’ specialist staff (physio-
therapists, dietitians, occupational therapists) but deliv-
ered by a single specifically trained GRA who develops
a close relationship with the patient. We tested our
model in a feasibility RCT and showed that markedly
enhanced levels of treatments could be successfully
delivered with this model, and the GRAs could function
autonomously across specialist boundaries in the acute
hospital.9 We further refined our service model to
include a GRA training programme, predefined
competencies and input from critical care staff to
provide information to patients and families.
METHODS
Trial objectives
Our primary objective is to evaluate the impact on
physical, psychological and social functioning of a novel
complex intervention strategy to enhance delivery of
physical and nutritional rehabilitation to patients
during the 3 months following ICU discharge. Our
secondary objectives are to evaluate the cost-effectiveness
of our approach and compare patient and carer expe-
riences and satisfaction between usual care and the new
strategy.
General design
RECOVER is a prospective, randomised, parallel group,
controlled trial with concealment of outcome assess-
ment. We are comparing our novel intervention with
usual care. A schematic diagram describing the trial
structure is shown in figure 1. The primary study
outcome is the Rivermead Mobility Index (RMI) at
3 months postrandomisation, which is a measure of
physical function in relation to mobility. As this is a trial
of a complex intervention with potential effects on many
outcomes important to patients and health services, we
are measuring a range of secondary outcomes during
12 months of follow-up (table 1). The full trial protocol
is available on the Edinburgh Clinical Trials Unit
(ECTU) website: http://www.clinicaltrials.ed.ac.uk.
Trial setting
The trial is taking place in Lothian Health Board’s two
major acute hospitals, which serve Edinburgh and the
surrounding region. The hospitals are run as a single
organisation with each major specialty grouping
managed by a clinical director and management team.
The critical care service is run as a discrete directorate
with a single general critical care unit on each site. The
Edinburgh Royal Infirmary ICU cares for approximately
700 mechanically ventilated patients each year and the
Western General hospital ICU approximately 450
patients. Cardiac surgery and paediatric critical care are
provided in separate ICUs. Further information about
the critical care setting is available in the Scottish
Intensive Care Society Audit report (http://www.sicsag.
scot.nhs.uk/).
Subject screening and selection
All ICU admissions will be accounted for, and those
receiving 48 h of continuous ventilation will be screened
for eligibility. Inclusion criteria are the patient required
$48 h of continuous invasive (via an endotracheal
and/or tracheostomy tube) mechanical ventilation in
the ICU and the consultant in charge of the patient
considers them fit for discharge from the ICU. Exclusion
criteria are a primary neurological admission diagnosis
(brain trauma, intracerebral bleed, stroke, Guillaine
Barre syndrome); the clinician in charge of care has
agreed with the patient and/or family that only palliative
care will be provided; patients currently receiving home
ventilation or planning to commence a programme of
home ventilation; patients expected to be discharged
from ICU to a non-study hospital where the intervention
cannot be received; gaining informed consent following
the intervention or follow-up is not feasible due to
communication difficulties; the patient currently
enrolled in another RCT with similar endpoints and
aged <18 years at the time of screening. The recruit-
ment window will be up to 7 days from the time the
patient fulfils entry criteria.
Consent
The study involves participants who may lack capacity as
a result of acute illness. For these patients, the Adults
with Incapacity Act (Scotland; 2000) applies. Patients
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Stage of patient journey
ICU discharge
Ward-based care
Hospital discharge
Home (or posthospital 
residence)
Variable duration
Variable duration
Outcome assessments 3 months postrandomisation
Outcome assessments 6 months postrandomisation
Outcome assessments 12 months postrandomisation
Figure 1 The general structure of the RECOVER trial.
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with mental capacity will be approached for consent to
participate in the trial. For those lacking mental capacity,
the welfare attorney or next of kin will be approached
for consent. For patients enrolled with this approach,
patients will be approached for consent to remain in the
trial once they regain capacity. The study information
sheets are available on the ECTU website (http://www.
clinicaltrials.ed.ac.uk).
Sample size
Based on our pilot study, we estimated that the mean
(SD) RMI at 3 months postrandomisation will be 10
(4.3), with normal mobility being 15 on a 0e15 scale.
Our pilot data suggested a change from baseline to
3 months in RMI of 2 (SD 5) is currently typical.9 We
have powered the study to detect an improvement in the
change from baseline RMI of 2 points at 3 months in the
intervention group compared with usual care. This
would be a clinically relevant difference in physical
disability for patients in relation to activities of daily
living and independence. To detect this difference, we
require 100 evaluable patients per group at 3 months
(80% power; 5% significance level). Assuming a 12%
death rate before 3 months (based on pilot work) and
Table 1 The patient outcomes measured in the trial
Method of assessment Outcome
Measurement tool (where
appropriate)
Primary outcome Research coordinator
blinded to group
allocation
Physical function Rivermead Mobility Index 3 months
postrandomisation
Secondary outcomes
Hospital Research coordinators Length of stay
ICU readmission rate
Survival to hospital discharge
Weekly physical function
Weekly levels of fatigue,
breathlessness, appetite, pain
and joint stiffness
Weekly presence of delirium
Weekly hand grip strength
Rivermead Mobility Index
Visual analogue scores
Confusion-Agitation Method for ICU
Hand grip dynamometry
3 months Research coordinator
blinded to group
allocation
HRQoL
Levels of fatigue, breathlessness,
appetite, pain and joint stiffness,
patient satisfaction*, healthcare
resource use, anxiety and
depression
Nutritional status (subjective global
assessment of nutrition), weight/BMI,
hand grip strength, physical mobility,
post-traumatic stress disorder symp-
tomatology
Total, Physical Component Score and
Mental Component Score
SF-12 score, Visual analogue score
Patient satisfaction measure, Health
Economic Questionnaire, Hospital
Anxiety and Depression (HAD)
Questionnaire
Physical component of the
Subjective Global Assessment
of Nutrition tool
Hand grip dynamometry, 2 m timed up-
and-go time, Davidson’s Trauma Scale
Score (DTS)
6 months Postal questionnaires Survival, physical function
HRQoL
Levels of fatigue, breathlessness;
appetite; pain and joint stiffness,
Healthcare resource use, Anxiety
and depression
Post-traumatic stress disorder
symptomatology
Rivermead Mobility Index, Total,
Physical Component Score, and
Mental Component Score SF-12
score, Visual analogue score
Health economic questionnaire,
Hospital Anxiety and Depression
(HAD) Questionnaire
Davidson’s Trauma Scale Score (DTS)
12 months Postal questionnaires Survival, Physical function
HRQoL
Levels of fatigue, breathlessness,
appetite, pain and joint stiffness
Healthcare resource use, anxiety
and depression
Post-traumatic stress disorder
symptomatology
Rivermead Mobility Index, Total,
Physical Component Score, and
Mental Component Score SF-12
score, Visual analogue score
Health Economic Questionnaire, HAD
Questionnaire
Davidson’s Trauma Scale Score (DTS)
*The patient satisfaction measure used in the trial was derived based on data obtained in the pretrial work, especially the qualitative research in
reference14. The tool is available on the RECOVER page of the ECTU website (http://www.clinicaltrials.ed.ac.uk).
HRQoL, health-related quality of life; ICU, intensive care unit.
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95% follow-up of remaining patients at 3 months (facil-
itated by home visits by research nurses), we require to
randomise 240 patients in total. Using local audit data,
we estimated that 498 eligible patients will be cared for
each year of whom 309 will be discharged alive from
ICU. Assuming 70% enrolment, we expect to enrol 216/
year or 18/month. The planned recruitment period is
therefore 14 months.
Method of assignment to treatment groups
Patients will be randomised 1:1 to receive either
existing usual care or the novel intervention. Random-
isation will be by a remote computer-based telephone
system to ensure allocation concealment. At random-
isation, minimisation with a random element will be
used to balance the following baseline variables: age
(>65 vs #65 years); disability at study entry (RMI 0e5 vs
6e10 vs 11e15); nutritional status at randomisation
(physical assessment element of the Subjective Global
Assessment of nutrition16: malnourished versus well
nourished); the presence/absence of delirium (using
CAM-ICU) and the ward destination of patient (surgical
vs medical).
Study intervention
Duration
The study intervention will start from the time of patient
randomisation, which will be within 48 h of consent, and
last until 3 months postrandomisation. Patients are
expected to require variable periods of time in the acute
hospital and the community during the 3-month inter-
vention, depending on individual health status.
Following the 3-month assessment, all patients will
receive usual care irrespective of their location, but
relevant healthcare professionals will be made aware of
any key issues by the research team to ensure patient
safety. Based on audit data, we expect only a small
proportion of patients to remain in hospital at 3 months
when the primary outcome is measured.
Description of treatments received
RECOVER is a complex intervention trial and, as
recommended by the MRC complex intervention
framework, we are describing the process of care
received in each group in detail.17 To achieve this, we
have identified four key stages of the patient pathway
during which we believe key and important components
of rehabilitation occur. These comprise the immediate
post-ICU discharge period (stage 1); ward-based reha-
bilitation in the acute hospital (stage 2); acute hospital
discharge planning (stage 3) and the posthospital
discharge period (stage 4). These stages will have
differing durations and timings in relation to random-
isation according to individual patient requirements.
The processes and treatments that we want to measure
during each stage have been defined a priori and will be
recorded prospectively according to a proforma (see
data collection and table 2).
Intervention group procedures
Generic rehabilitation assistants
GRAs will be employed to work exclusively with patients
randomised to the intervention group. We previously
described the concept of the specialist critical care
rehabilitation assistant.15 For RECOVER, we calculated
that the workload would require 2.5 whole time
Table 2 The process measures and treatments recorded prospectively to describe the rehabilitation received during the
intervention period
Stage Process Data recorded by
One: post-ICU discharge Visits by ICU clinical staff
Provision of rehabilitation manual by research team
Research nurse
from medical notes
Two: ward-based rehabilitation
Documented for each week
(or part week) in the acute hospital
Number of visits (and content) by physiotherapy
staff, occupational therapy, SLT, dietetic and other
non-parent specialty staff
Number of visits by GRA (intervention group only)
Total numbers of therapy sessions in physiotherapy,
dietetic, occupational health, SLT and other
relevant categories
Patient-centred goals documented
Research nurse
from medical notes
Three: hospital discharge Number patient discharged to rehabilitation facility
For patients discharged to home/community:
Proportion of patients receiving home visit occurred
Proportion of patients with letter to general
practitioner specifically documenting
rehabilitation issues
Research nurse
from medical notes
Four: post-hospital discharge
to 3-month outcome measure
Total contacts with GRA during post-hospital
discharge period
Contact with healthcare services
Research nurse
at 3 months assessment
GRA, generic rehabilitation assistant; ICU, intensive care unit.
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equivalent posts working flexibly across the two hospitals
under the supervision of a multidisciplinary rehabilita-
tion team comprising physiotherapists and dietitians and
some input from speech and language therapy and
occupational therapy. The GRAs will be trained to use
systematic screening tools for common problems and
deliver therapy according to predefined competencies.
All GRAs will receive a 4-week training programme prior
to starting the trial. A description of the training
programme is available on the RECOVER page of the
ECTU website (http://www.clinicaltrials.ed.ac.uk).
Stage 1 interventions
A lay summary will be produced by an ICU consultant or
nominated member of staff and made available to
patients, their relatives and relevant healthcare profes-
sionals providing a brief summary of key events that
occurred during the patient’s stay in intensive care. All
patients will receive a visit from a Critical Care consultant
or nominated deputy, organised by the GRA for an
appropriate time mutually convenient to the patient, the
consultant and the patient’s relative (if they wish to
attend). A predefined topic guide will be used to cover
key aspects of the critical illness pathway and will include
possible short- and long-term complications. The
proforma used to dictate the lay summary, and the
topic guides used for the consultant visit are available on
the RECOVER page of the ECTU website (http://www.
clinicaltrials.ed.ac.uk).
Stage 2 interventions
The GRA will deliver an enhanced and coordinated
rehabilitation under the supervision of the multidisci-
plinary specialists, based on frequent visits according to
the requirements of individual patients and clinical
workload. Key elements will include the following: indi-
vidualised goal setting with each patient in a range of
areas; a clear plan of exercises and nutrition interven-
tions aimed at achieving the goals; regular systematic
screening for anticipated problems relating to nutrition
and physical disability using tools agreed with physio-
therapy, dietetic, occupational therapy and speech and
language therapy teams. These will be used to trigger
specialist input using predefined thresholds or criteria.
The screening tools used by the GRAs to detect patient
problems and refer to more senior specialists within the
rehabilitation team are available on the RECOVER page
of the ECTU website (http://www.clinicaltrials.ed.ac.uk).
Stage 3 interventions
The GRA will input into hospital discharge planning by
the multidisciplinary team based on their detailed
knowledge of ongoing patient problems and issues.
Stage 4 interventions
After discharge home, the GRA will contact the patient
within the first week to enquire how they are managing
at home and whether there are any issues that have
arisen. The patient will be provided with a telephone
number at discharge, through which they can contact
the GRA to discuss any issues.
Usual care procedures
The NICE guideline makes recommendations regarding
best practice but acknowledges that these are largely
expert/opinion based or based on extrapolation from
other rehabilitation settings.6 Our pretrial work showed
that the intensity of physiotherapy and dietetic input was
limited and that ward visits by ICU clinicians is not
routine care. The strongest evidence for effectiveness on
physical recovery was provision of a self-help manual,
supported by expert staff, during the weeks after ICU
discharge.11 For the purpose of RECOVER, we intend
‘usual care’ to be externally valid as representative of
practice in the NHS (or other healthcare systems). We
will include provision of an ICU recovery manual as part
of ‘usual care’ because data exist to support this inter-
vention. Otherwise rehabilitation will be provided by
NHS multidisciplinary teams using the current arrange-
ments in the study hospitals, which does not include any
specialist critical care GRAs. Detailed process data
collection for both groups will ensure that the treatment
received in both arms is well described.
A summary of the interventions expected to occur at
each stage of recovery for each group is summarised in
figure 2.
Data collection
Baseline data
We will record age, gender, social class (postcode based),
Functional Co-morbidity Index (based on prehospital
admission data), ICU diagnosis (Scottish Intensive Care
Society code) and APACHE II score at ICU admission. At
randomisation, we will record prerandomisation ICU
length of stay and total hospital length of stay; days of
mechanical ventilation, vasopressor use and renal
replacement therapy; source of nutrition at study entry;
Sequential Organ Failure Assessment score at random-
isation; delirium at randomisation (CAM-ICU tool); RMI
and the physical component of the Subjective Global
Assessment of Nutrition tool score.
Process of care data
Detailed quantification of predefined elements of reha-
bilitation will be recorded on a weekly basis by research
staff from randomisation until hospital discharge. These
fields are summarised in table 2.
Outcome data
The primary and secondary outcome data are summar-
ised in table 1. At 3 months postrandomisation, all
surviving participants will be contacted and a home visit
undertaken by community research nurses blinded to
group allocation, with no previous knowledge of the
participant. Patients remaining in hospital at 3 months
will be assessed by research staff blinded to group allo-
cation. At 6 and 12 months, postrandomisation surviving
patients will be contacted by the trial office and
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outcomes measured using postal questionnaires. A
predefined standard operating procedure will be used to
maximise rates of follow-up and completion of the
primary and secondary outcomes; this is summarised on
the RECOVER page of the ECTU website (http://www.
clinicaltrials.ed.ac.uk). Patient survival up to 10 years will
be ascertained through linkage to the Information and
Services Division Database through the Scottish Inten-
sive Care Society Audit Database. The proposed
CONSORT diagram is shown in figure 3.
Data management
All data will be collected to paper Case Record Files and
entered into a bespoke database. Quality checks will
generate queries, which will be resolved with research site
staff. All data queries will be resolved prior to locking the
database for analysis. Data will be stored in the ECTU or
associated data archiving facilities for a minimum of
15 years to enable subsequent ascertainment of long-term
health status through national database linkage.
Data analysis
The primary analysis will be performed according to the
intention-to-treat principle. As the trial is testing
a complex intervention involving health service rede-
sign, we do not propose a separate analysis of patients
who did not receive any or certain elements of the
intervention. The primary outcome measure, RMI at
3 months postrandomisation, will be compared between
the groups using analysis of covariance to adjust for
baseline RMI and for the factors included in the mini-
misation algorithm. A sensitivity analysis will be
performed where the lowest possible value of RMI (0) is
imputed for those patients who die within 3 months of
randomisation. A similar approach will be used to
analyse the secondary outcome measures. A detailed
analysis plan has been written for the baseline variables,
process measures and primary and secondary outcome
variables. The analysis plan is available on the ECTU
website (http://www.clinicaltrials.ed.ac.uk).
Qualitative study
We plan to maximise the information obtained about
the intervention using a mixed methods approach,
incorporating qualitative research. Focus group inter-
views will be conducted, recorded and transcribed at
each of the participating hospitals.
Patients and carers
Using purposive sampling, we will invite 8e10 patients
and carers from the ‘usual care’ and intervention groups
at each site to participate in separate focus groups.
Participants will be invited to discuss their experiences of
recovery and rehabilitation up to 3 months post-ICU
discharge. We will explore key issues and concerns and the
ways in which multi-disciplinary input impacted upon
recovery both during the acute hospital phase and
following discharge home. A comparative analysis between
the ‘usual care’ and intervention focus groups will explore
the impact of the intervention on participants’ key issues
and concerns.
Healthcare professionals
Using purposive sampling, we will invite 8e10 repre-
sentatives from key healthcare disciplines at each site to
participate in focus group interviews towards the end of
Figure 2 A description of the
conceptual stages in the patient
journey and the intended
differences in the rehabilitation
provided for the two groups. Stage 1: ICU discharge
Within 1 week of ICU discharge 
according to individual patient 
characteristics
Stage in patient pathway
Usual care group Intervention group
Component of rehabilitation
Provision of ICU recovery manual
Visit by ICU staff member
Structured discussion/explanation 
and provision of ICU recovery manual 
Provision of summary of ICU stay in 
lay language
Introduction to generic rehabilitation 
assistant and explanation of 
rehabilitation strategy
Stage 2: Ward-based 
rehabilitation
Ongoing until hospital discharge
Weekly goal setting
Daily visits from generic 
rehabilitation assistant to deliver 
agreed strategy to achieve goals
Active problem identification and 
solving using screening tools and 
triggers
Usual care pattern of 
multidisciplinary team input
No involvement by generic 
rehabilitation assistant
Stage 3: Hospital 
discharge planning
Around time of planned discharge
Usual care pattern of discharge 
planning by parent teams 
ICU visit as determined by parent 
teams
Planning with input from generic 
rehabilitation assistant to needs 
assessment
Coordinated provision of critical 
illness-specific information to GP 
ICU visit prior to discharge
Stage 4: Posthospital 
discharge
From hospital discharge to up to 3- 
month follow-up point
Usual care with no specific ICU-
based input
Provision of generic rehabilitation 
assistant contact details to all 
patients
At least 1 telephone contact 
within one week of discharge
Other input according to individual 
patient preference
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the recruitment period. Drawing upon our analysis of
the research logs, participants will be invited to discuss
barriers to the delivery and coordination of patient-led
care among both groups and perceptions (including
acceptability) of the GRAs as a novel strategy for the
rehabilitation of patients after ICU discharge.
Assessment of research logs kept by GRAs
The GRAs will keep a log throughout the trial to record
their experience of the novel role. Using thematic
analysis, we will analyse these to categorise the principle
barriers to the intervention and successful strategies in
the implementation of the intervention both in indi-
vidual patients and across ward and hospital settings.
These data will supplement the quantitative measure-
ment of process outcomes and facilitate the translation
of findings into routine care.
Blood sampling for biomarker inflammation study
A substudy will investigate the prevalence of persisting
inflammation following ICU discharge and its relation-
ship with recovery. For patients who consent to addi-
tional blood sampling, a 10 ml blood sample will be
collected at randomisation, weekly until hospital
discharge and at the 3-month visit, and stored frozen as
plasma and serum. Biological substances involved in the
inflammatory response will subsequently be measured
and related to measures of physical recovery.
Health economic evaluation
Cost-effectiveness will be estimated using a prospective
within trial analysis of treatment effects analysed on an
intention-to-treat basis and a decision model of long-
term costs and health outcomes. The primary endpoint
for the economic analysis will be incremental cost-
effectiveness ratios comparing the intervention group
with the usual standard of care impact, focusing on
health service use and HRQoL. Health service costs will
be assigned to the type and intensity of resource use
measured by rehabilitation interventions/contacts,
medications, hospital clinic attendances and hospital-
isation episodes from randomisation to 12 months of
follow-up. The health economic questionnaire used in
the study is available of the ECTU website (http://www.
clinicaltrials.ed.ac.uk). Unit costs will reflect a mixture
of approaches including activity-based analyses of
resource consumption for specific rehabilitation inter-
ventions alongside average per diem inpatient costs
calculated on a specialty-specific basis using the Scottish
Health Service Costs system. Endpoints for health
effects will include survival times and quality-adjusted
survival times. Quality-adjusted survival times per life
years will be calculated for all randomised patients using
the HRQoL measures. These within trial analyses will
be integrated into a decision model of long-term costs
and health effects. We propose to use a Monte-Carlo
microsimulation model. Base case analysis, using the
intention-to-treat results, and sensitivity analysis will be
conducted by varying key model parameters and critical
assumptions over plausible ranges/distributions. The
decision model will also permit the analysis of cost-
effectiveness conditional on prespecified patient
subgroups to allow for heterogeneity in the case mix of
patients receiving intensive care and their baseline
condition at ICU discharge. A full description of the
proposed analysis can be found in the full protocol on
the RECOVER page of the ECTU website (http://www.
clinicaltrials.ed.ac.uk).
RESEARCH GOVERNANCE
The trial will be carried out under the principle of the
International Conference for Harmonisation of Good
Clinical Practice guidelines. Specifically, the research
sponsors’ (Edinburgh University/Lothian Health
Board) guidelines for adverse event reporting policy and
Standard Operating Procedures will be followed. These
are consistent with adverse event reporting guidelines
from the National Research Ethics Service for safety
reporting in research other than clinical trials of inves-
tigational medicinal products. A monitoring plan will be
agreed with the sponsor early in the trial.
ETHICS
The trial has received a favourable ethical opinion by the
Scotland A Research Ethics Committee (Ref 10/MRE00/
18) and is approved by the NHS Lothian R&D depart-
ment (Ref 2010/R/AN/02).
All ICU admissions during the 
Trial recruitment period
All patients requiring ≥48 h
mechanical ventilation 
in the ICU
All patients surviving to ICU 
discharge
Non-eligible patients
All eligible patients
Consented
Reasons not 
approached for consent
Approached for consent
Declined consent
Randomised
Not randomised
Intervention Usual care
3 months post
randomisation
3 months post
randomisation
6 months post
randomisation
12 months post
randomisation
6 months post
randomisation
12 months post
randomisation
Follow
-up
Deaths in ICU
Figure 3 The CONSORT diagram that will be reported to
account for all patients screened for eligibility, approached for
consent, enrolled in the trial and followed up and the
predefined time points. For each cell, the numbers of patients
will be included. For the follow-up time points, the numbers of
patients completing the various outcome measures will be
recorded.
8 Walsh TS, Salisbury LG, Boyd J, et al. BMJ Open 2012;2:e001475. doi:10.1136/bmjopen-2012-001475
Recovery following intensive care
 o
n
 January 30, 2020 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2012-001475 on 2 July 2012. Downloaded from 
TRIAL MANAGEMENT
The trial will be managed by a Trial Management Group
and overseen by a Trial Steering Group, which includes
an independent Chairman, two independent clinical
specialists, and a lay representative. A Data Monitoring
and Safety Committee will monitor the progress, quality
and safety of the trial. The membership of these
committees is available on the RECOVER page of the
ECTU website (http://www.clinicaltrials.ed.ac.uk). The
trial registration number is ISRCTN: 09412438 and
the trial is registered on the NIHR Clinical Research
Network (Critical Care portfolio; number 8849).
RELATED STUDIES
RECOVER is part of a programme of work exploring
rehabilitation needs and intervention strategies
following critical illness. Two other studies (RELIN-
QUISH study and EATEN study) will sample cases
enrolled in the trial.
The RELINQUISH study (REcovery following critical
illness: a Longitudinal Qualitative exploration of
perceived healthcare and Support needs among survi-
vors; developing timely interventions after Hospital
discharge; NIHR portfolio number 9986) will invite up
to 24 participants enrolled in the RECOVER trial to each
take part in four interviews over the 12 months following
ICU discharge. Purposive sampling will be used to enrol
equal numbers from each of the RECOVER groups with
representation from relevant subgroups according to
age, gender, duration of mechanical ventilation, ward
discharge destination, occupational status and level of
social support. The study aims are to examine the ways in
which perceived healthcare and support needs change
over time, to assess the extent to which these needs are
currently met by formal and informal community-based
resources, to identify potential service improvements for
survivors of critical illness throughout the recovery
process following discharge into the community and to
explore the impact of the RECOVER intervention upon
the perceived healthcare and support needs of survivors
following discharge into the community. RELINQUISH
is funded by the Health Services Research Unit of NHS
Lothian; the PI is Dr Pam Ramsay (coinvestigator for the
RECOVER trial).
The EATEN study (An Exploration of the bArriers to
nutritional intake after inTENsive care; NIHR portfolio
number 10631) will invite up to 17 participants in the
RECOVER study to participate in sequential hospital
based interviews and field work, followed by an interview
3 months following ICU discharge. The study will
explore the barriers to achieving nutritional recovery
during this period of recovery and is funded as part of
a dietetic PhD Fellowship for Judith Merriweather
(coinvestigator for the RECOVER trial) by the Chief
Scientist’s Office, Scotland.
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